WO2008136398A1 - 高濃度アミノ酸含有培地を用いた細胞の培養方法 - Google Patents

高濃度アミノ酸含有培地を用いた細胞の培養方法 Download PDF

Info

Publication number
WO2008136398A1
WO2008136398A1 PCT/JP2008/058046 JP2008058046W WO2008136398A1 WO 2008136398 A1 WO2008136398 A1 WO 2008136398A1 JP 2008058046 W JP2008058046 W JP 2008058046W WO 2008136398 A1 WO2008136398 A1 WO 2008136398A1
Authority
WO
WIPO (PCT)
Prior art keywords
amino acid
culture
cell culture
culture method
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/058046
Other languages
English (en)
French (fr)
Inventor
Satoshi Katayama
Shouhei Kishishita
Kunihiko Kodaira
Makoto Sadamitsu
Yoshinori Takagi
Hiroki Matsuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39943505&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2008136398(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to ES08752120.9T priority Critical patent/ES2624185T3/es
Priority to JP2009512972A priority patent/JP5576115B2/ja
Priority to EP08752120.9A priority patent/EP2154244B1/en
Priority to DK08752120.9T priority patent/DK2154244T3/en
Priority to US12/451,003 priority patent/US20110137012A1/en
Publication of WO2008136398A1 publication Critical patent/WO2008136398A1/ja
Anticipated expiration legal-status Critical
Priority to US16/297,086 priority patent/US11661579B2/en
Priority to US18/309,489 priority patent/US20230272336A1/en
Priority to US19/312,697 priority patent/US20250388856A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/303—Liver or Pancreas
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

　所望のタンパク質を生産する細胞を培養して当該タンパク質を製造するための、生物由来培地成分を極力排除した培地による新規な培養方法を提供する。すなわち、培養液中の特定のアミノ酸を高濃度に維持して培養することを特徴とする培養方法、およびこの方法に用いる細胞培養用流加培地を提供する。
PCT/JP2008/058046 2007-04-26 2008-04-25 高濃度アミノ酸含有培地を用いた細胞の培養方法 Ceased WO2008136398A1 (ja)

Priority Applications (8)

Application Number Priority Date Filing Date Title
ES08752120.9T ES2624185T3 (es) 2007-04-26 2008-04-25 Método de cultivo celular que utiliza un medio enriquecido con aminoácidos
JP2009512972A JP5576115B2 (ja) 2007-04-26 2008-04-25 高濃度アミノ酸含有培地を用いた細胞の培養方法
EP08752120.9A EP2154244B1 (en) 2007-04-26 2008-04-25 Cell culture method using amino acid-enriched medium
DK08752120.9T DK2154244T3 (en) 2007-04-26 2008-04-25 CELL CULTIVATION PROCEDURE WHEN AN ACID-ENRICHED MEDIUM IS USED
US12/451,003 US20110137012A1 (en) 2007-04-26 2008-04-25 Cell culture method using amino acid-enriched medium
US16/297,086 US11661579B2 (en) 2007-04-26 2019-03-08 Cell culture method using amino acid-enriched medium
US18/309,489 US20230272336A1 (en) 2007-04-26 2023-04-28 Cell culture method using amino acid-enriched medium
US19/312,697 US20250388856A1 (en) 2007-04-26 2025-08-28 Cell culture method using amino acid-enriched medium

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007117426 2007-04-26
JP2007-117426 2007-04-26

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12/451,003 A-371-Of-International US20110137012A1 (en) 2007-04-26 2008-04-25 Cell culture method using amino acid-enriched medium
US16/297,086 Division US11661579B2 (en) 2007-04-26 2019-03-08 Cell culture method using amino acid-enriched medium

Publications (1)

Publication Number Publication Date
WO2008136398A1 true WO2008136398A1 (ja) 2008-11-13

Family

ID=39943505

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/058046 Ceased WO2008136398A1 (ja) 2007-04-26 2008-04-25 高濃度アミノ酸含有培地を用いた細胞の培養方法

Country Status (9)

Country Link
US (4) US20110137012A1 (ja)
EP (1) EP2154244B1 (ja)
JP (1) JP5576115B2 (ja)
KR (1) KR101574355B1 (ja)
CN (2) CN105567627B (ja)
DK (1) DK2154244T3 (ja)
ES (1) ES2624185T3 (ja)
TW (1) TWI601823B (ja)
WO (1) WO2008136398A1 (ja)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010050448A1 (ja) * 2008-10-28 2010-05-06 中外製薬株式会社 ペプチド含有動物細胞培養用培地
WO2012017925A1 (ja) 2010-08-02 2012-02-09 協和発酵キリン株式会社 物質の製造方法
JP2013524824A (ja) * 2010-04-26 2013-06-20 ノバルティス アーゲー 改良型細胞培養培地
JP2013536683A (ja) * 2010-08-31 2013-09-26 フリエスランド ブランズ ビー．ブイ． 真核細胞のための培養培地
JP2017523798A (ja) * 2014-08-11 2017-08-24 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 真核細胞の比生産速度を増加させる方法
JP2019500878A (ja) * 2016-01-06 2019-01-17 オンコバイオロジクス，インコーポレイティド モノクローナル抗体組成物中の高分子量種、酸性荷電種、及び断片の低減
US10662237B2 (en) 2009-08-06 2020-05-26 Genentech, Inc. Method to improve virus filtration capacity
JPWO2021090888A1 (ja) * 2019-11-05 2021-05-14

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008136398A1 (ja) 2007-04-26 2008-11-13 Chugai Seiyaku Kabushiki Kaisha 高濃度アミノ酸含有培地を用いた細胞の培養方法
US20110262965A1 (en) 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
TWI583788B (zh) 2011-09-16 2017-05-21 安美基公司 細胞培養之預程式化無回饋控制之連續進料
KR101318498B1 (ko) * 2012-03-08 2013-10-16 한화케미칼 주식회사 재조합 단백질의 생산성 향상을 위한 배양용 배지 첨가용 조성물
US11390663B2 (en) 2013-10-11 2022-07-19 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
CN109563161A (zh) 2016-02-03 2019-04-02 安口生物公司 用于提高抗体稳定性的缓冲制剂
WO2018016622A1 (ja) 2016-07-22 2018-01-25 日産化学工業株式会社 液状の培地組成物の製造方法および製造装置
WO2018018613A1 (zh) 2016-07-29 2018-02-01 广东东阳光药业有限公司 一种提高抗体纯度的细胞培养基和培养方法
CN113337562B (zh) * 2021-05-24 2022-06-03 宁波人健药业集团股份有限公司 使用CHO细胞高效发酵生产rhCG的方法
ES2944758B2 (es) * 2021-12-23 2023-11-14 Stirmot S L Rastrillo hilerador

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01231887A (ja) * 1987-10-13 1989-09-18 Dr Karl Thomae Gmbh タンパク質の調製法
JPH04501660A (ja) * 1988-09-23 1992-03-26 カイロン　コーポレーション 増強された細胞増殖、培養寿命および生産物発現のための細胞培養培地
JPH05252942A (ja) * 1991-05-14 1993-10-05 Boehringer Mannheim Gmbh 動物起源のタンパク質材料なしで哺乳類細胞を培養するための血清不含の培地および哺乳類細胞を培養する方法
JPH0899902A (ja) 1994-09-30 1996-04-16 Chugai Pharmaceut Co Ltd Ｉｌ−６レセプター抗体を有効成分とする未熟型骨髄腫細胞治療剤
WO2006006693A1 (ja) 2004-07-09 2006-01-19 Chugai Seiyaku Kabushiki Kaisha 抗グリピカン３抗体

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3734632A1 (de) * 1987-10-13 1989-04-27 Thomae Gmbh Dr K Verfahren zur herstellung von t-pa
US6048728A (en) * 1988-09-23 2000-04-11 Chiron Corporation Cell culture medium for enhanced cell growth, culture longevity, and product expression
FR2657783B1 (fr) * 1990-02-07 1992-05-29 Fondation Nale Transfusion San Procede de preparation de derives sanguins et derives obtenus par ce procede.
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
GB2251249B (en) 1990-12-28 1995-06-21 Mogam Biotech Res Inst High-density medium for animal cell culture
US5641678A (en) * 1994-01-18 1997-06-24 Smithkline Beecham Corporation Serum-free culture medium for drosphila insect cells
US6103529A (en) * 1996-10-10 2000-08-15 Life Technologies, Inc. Animal cell culture media comprising peptides derived from rice
US20020012991A1 (en) 1997-04-07 2002-01-31 Florence Chua Nee Ho Kit Fong Cell culture media for enhanced protein production
EP1229125A4 (en) 1999-10-19 2005-06-01 Kyowa Hakko Kogyo Kk PROCESS FOR PREPARING A POLYPEPTIDE
DE10011998A1 (de) 2000-03-11 2001-09-20 Forschungszentrum Juelich Gmbh Wirkstoffkombination sowie Verfahren zur Kultivierung von Zellen und Verfahren zur Herstellung der Wirkstoffkombination
PT1356073E (pt) * 2000-10-20 2010-02-15 Bioneer As Método de fermentação aperfeiçoado para a produção de produtos genéticos heterólogos em bactérias do ácido láctico
EP1360314B1 (en) * 2001-02-15 2009-01-14 Centocor, Inc. Chemically defined medium for cultured mammalian cells
AU2002316230A1 (en) 2001-06-13 2002-12-23 Genentech, Inc. Methods of culturing animal cells and polypeptide production in animal cells
WO2004099396A1 (en) 2003-05-09 2004-11-18 Crucell Holland B.V. Cultures of e1-immortalized cells and processes for culturing the same to increase product yields therefrom
US6933137B2 (en) 2003-05-16 2005-08-23 Aventis Pasteur Animal component free meningococcal polysaccharide fermentation and seedbank development
TWI364458B (en) 2004-08-27 2012-05-21 Wyeth Res Ireland Ltd Production of tnfr-lg
TWI384069B (zh) 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
US7335491B2 (en) 2004-08-27 2008-02-26 Wyeth Research Ireland Limited Production of anti-abeta
AU2005302516A1 (en) * 2004-10-29 2006-05-11 Centocor, Inc. Chemically defined media compositions
ES2361559T3 (es) * 2004-11-02 2011-06-20 Ares Trading S.A. Medio de cultivo de células exento de suero para mamíferos.
JP4710008B2 (ja) * 2005-04-20 2011-06-29 国立大学法人東北大学 高代謝能を有する培養筋細胞の作製方法
CN1778903A (zh) * 2005-09-29 2006-05-31 华东理工大学 一种动物细胞高密度连续灌注培养方法
AU2007239679B2 (en) * 2006-04-13 2012-10-11 Chugai Seiyaku Kabushiki Kaisha Taurine transporter gene
CN100569940C (zh) 2006-08-16 2009-12-16 华东理工大学 人胚胎肾(hek)293细胞无血清培养基
AU2007294731B2 (en) * 2006-09-13 2014-04-17 Abbvie Inc. Cell culture improvements
SI2078071T1 (sl) 2006-11-08 2015-05-29 Wyeth Llc Racionalno zasnovana gojišča za celično kulturo
WO2008136398A1 (ja) 2007-04-26 2008-11-13 Chugai Seiyaku Kabushiki Kaisha 高濃度アミノ酸含有培地を用いた細胞の培養方法
US8252557B2 (en) * 2008-10-28 2012-08-28 Chugai Seiyaku Kabushiki Kaisha Peptide-containing culture medium for culturing animal cell

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01231887A (ja) * 1987-10-13 1989-09-18 Dr Karl Thomae Gmbh タンパク質の調製法
JPH04501660A (ja) * 1988-09-23 1992-03-26 カイロン　コーポレーション 増強された細胞増殖、培養寿命および生産物発現のための細胞培養培地
JPH05252942A (ja) * 1991-05-14 1993-10-05 Boehringer Mannheim Gmbh 動物起源のタンパク質材料なしで哺乳類細胞を培養するための血清不含の培地および哺乳類細胞を培養する方法
JPH0899902A (ja) 1994-09-30 1996-04-16 Chugai Pharmaceut Co Ltd Ｉｌ−６レセプター抗体を有効成分とする未熟型骨髄腫細胞治療剤
WO2006006693A1 (ja) 2004-07-09 2006-01-19 Chugai Seiyaku Kabushiki Kaisha 抗グリピカン３抗体

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"Affinity Chromatography Principles & Methods", 2003, GE HEALTHCARE, pages: 56 - 60
DULBECCO, R.; FREEMAN, G., VIROLOGY, vol. 8, 1959, pages 396
JOURNAL OF BIOSCIENCE AND BIOENGINEERING, vol. 100, no. 5, 2005, pages 502 - 510
KOTAIKOGAKUNYUMON: "Introduction to Antibody Engineering", 1994, CHIJINSHOKAN CO. LTD., pages: 102 - 104
NATURE, NEW BIOLOGY, vol. 230, 1971, pages 52
TAKESHI KOBAYASHI; HIROYUKI HONDA; TOKYO KAGAKU DOJIN: "Seibutsukagakukogaku", vol. 8, 2002, APPLIED LIFE SCIENCE SERIES

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252557B2 (en) 2008-10-28 2012-08-28 Chugai Seiyaku Kabushiki Kaisha Peptide-containing culture medium for culturing animal cell
WO2010050448A1 (ja) * 2008-10-28 2010-05-06 中外製薬株式会社 ペプチド含有動物細胞培養用培地
US10662237B2 (en) 2009-08-06 2020-05-26 Genentech, Inc. Method to improve virus filtration capacity
US11225513B2 (en) 2009-08-06 2022-01-18 Genentech, Inc. Method to improve virus filtration capacity
JP2013524824A (ja) * 2010-04-26 2013-06-20 ノバルティス アーゲー 改良型細胞培養培地
WO2012017925A1 (ja) 2010-08-02 2012-02-09 協和発酵キリン株式会社 物質の製造方法
JPWO2012017925A1 (ja) * 2010-08-02 2013-10-03 協和発酵キリン株式会社 物質の製造方法
JP2013536683A (ja) * 2010-08-31 2013-09-26 フリエスランド ブランズ ビー．ブイ． 真核細胞のための培養培地
JP2017523798A (ja) * 2014-08-11 2017-08-24 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 真核細胞の比生産速度を増加させる方法
US12338456B2 (en) 2014-08-11 2025-06-24 Hoffmann-La Roche Inc. Method for increasing the specific production rate of eukaryotic cells
JP2019500878A (ja) * 2016-01-06 2019-01-17 オンコバイオロジクス，インコーポレイティド モノクローナル抗体組成物中の高分子量種、酸性荷電種、及び断片の低減
JPWO2021090888A1 (ja) * 2019-11-05 2021-05-14
WO2021090888A1 (ja) 2019-11-05 2021-05-14 味の素株式会社 タンパク質の製造方法
CN114667351A (zh) * 2019-11-05 2022-06-24 味之素株式会社 蛋白质的制造方法
KR20220097421A (ko) 2019-11-05 2022-07-07 아지노모토 가부시키가이샤 단백질의 제조 방법
JP7513034B2 (ja) 2019-11-05 2024-07-09 味の素株式会社 タンパク質の製造方法
US12584156B2 (en) 2019-11-05 2026-03-24 Ajinomoto Co., Inc. Method for producing protein

Also Published As

Publication number Publication date
EP2154244A1 (en) 2010-02-17
DK2154244T3 (en) 2017-06-12
TWI601823B (zh) 2017-10-11
CN105567627B (zh) 2020-09-29
TW200914614A (en) 2009-04-01
HK1224337A1 (zh) 2017-08-18
US20190276795A1 (en) 2019-09-12
US11661579B2 (en) 2023-05-30
US20230272336A1 (en) 2023-08-31
EP2154244A4 (en) 2011-08-10
JP5576115B2 (ja) 2014-08-20
CN101663391A (zh) 2010-03-03
KR20100017298A (ko) 2010-02-16
KR101574355B1 (ko) 2015-12-11
CN105567627A (zh) 2016-05-11
ES2624185T3 (es) 2017-07-13
JPWO2008136398A1 (ja) 2010-07-29
EP2154244B1 (en) 2017-04-12
US20250388856A1 (en) 2025-12-25
US20110137012A1 (en) 2011-06-09

Similar Documents

Publication Publication Date Title
WO2008136398A1 (ja) 高濃度アミノ酸含有培地を用いた細胞の培養方法
Ho et al. Achieving high lipid productivity of a thermotolerant microalga Desmodesmus sp. F2 by optimizing environmental factors and nutrient conditions
Schippers et al. Cultivation of sponges, sponge cells and symbionts: achievements and future prospects
WO2008154014A3 (en) A method for culturing mammalian cells to improve recombinant protein production
WO2010096588A3 (en) Cell culture media containing combinations of proteins
WO2008118392A3 (en) Synthetic cell platforms and methods of use thereof
CA3005308C (en) Media and fermentation methods for producing polysaccharides in bacterial cell culture
GB2432846B (en) Medium and culture of embryonic stem cells
WO2009028631A1 (ja) 角膜内皮細胞接着促進剤
PE20090731A1 (es) Metodos de produccion de proteinas basados en medios de cultivos celulares que comprenden compuestos anti-senescencia
WO2011133902A3 (en) Cell culture medium comprising small peptides
WO2011116922A9 (de) Thermoresponsives substrat mit mikrogelen, verfahren zu dessen herstellung und kultivierungsverfahren für biologische zellen
EP4406615A3 (en) Method for the production of a glycosylated immunoglobulin
SI1828065T1 (sl) Postopek za povečano produkcijo bioplina v termofilnih, anaerobnih fermentorjih
AR073602A1 (es) Metodo para producir un aditivo para la degradacion enzimatica de micotoxinas y aditivo y uso del mismo
MY157298A (en) Process for simultaneous saccharification and fermentation for production of ethanol
WO2011021196A3 (en) Proton concentration topographies, methods and devices for producing the same
EA201491785A1 (ru) Способ ферментации
MX344896B (es) Método de operación de la fermentación de un substrato gaseoso que contiene monóxido de carbono.
TW201129698A (en) New cell culture method
DE602005002829D1 (de) Verwendung eines serumfreien zellkulturmediums zur produktion von il-18bp in säugerzellen
WO2009082208A3 (en) Trichome specific promoters
WO2010042484A3 (en) Photobioreactor system with high specific growth rate and low dilution rate
EP1881062A4 (en) METHOD FOR CULTURING MESENCHYMAL STEM CELL AND METHOD FOR PRODUCING SUPPORT MATERIAL FOR BIOLOGICAL TISSUE
WO2009080914A3 (fr) Méthode pour stimuler la prolifération de cellules différenciées appartenant au lignage chondrogénique

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880013018.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08752120

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2009512972

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12451003

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20097024422

Country of ref document: KR

Kind code of ref document: A

REEP Request for entry into the european phase

Ref document number: 2008752120

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 6935/CHENP/2009

Country of ref document: IN

Ref document number: 2008752120

Country of ref document: EP